L. Nathan Tumey (IMAGE)

Binghamton University

L. Nathan Tumey

Caption

Backed by a NIH grant, Binghamton researcher L. Nathan Tumey is advancing antibody-drug-conjugate technology for the treatment of cancer and immunological disorders, exploring flexible approaches for cell-specific drug delivery.

Credit

Binghamton University, State University of New York

Usage Restrictions

Credit to Binghamton University, State University of New York

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.